Option chain shows key data for GlucoTrack's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for GlucoTrack.

GlucoTrack (NASDAQ:GCTK) Stock, Option Chain

GlucoTrack

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

Businessman.Markets.Shutterstock

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AZEK

BTOG

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

New Oriental Education & Technology Group

GCTK

IMTE

LGHL

MGNX

MLGO

NVNI

RNAZ

RZLT

SGLY

SWIN

WINT

Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Stock,Market,Graph,Trading,Analysis,Investment,Financial,,Stock,Exchange,Financial

Intraday Update

ALUR

AUID

BHAT

BNTC

INNV

MCVT

OUST

PNBK

PSTV

RVSB

TNMG

USAR

XHLD

Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Screenshot 2025-03-18 at 5.54.31 PM

Health Care

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

GlucoTrack Inc

Press Releases

Glucotrack Announces ISO 13485:2016 Certification

Management

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Glucotrack Announces Reverse Stock Split

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Contracts

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

General

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Aethlon Medical

Autonomix Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Bluejay Diagnostics

Biomerica

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Know Labs

LogicMark

NanoVibronix

ENDRA Life Sciences

Nuwellis

Predictive Oncology

SINTX Technologies

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Venus Concept

Catheter Precision

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

Screenshot 2025-02-24 at 6.22.23 PM

Biotech

DXCM

Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

Screenshot 2025-01-06 at 6.34.13 PM

Advancing Clinical Studies, Meeting Regulatory Milestones, Strengthening Its Strategic Framework And More: The Past Year For Glucotrack, And What Lies Ahead

Screenshot 2024-12-03 at 7.43.04 PM

Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor

Screenshot 2024-10-03 at 5.30.47 PM

SENS

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology

Screenshot 2024-08-23 at 5.43.44 PM

Poster Presentations, Upcoming Human Trials, Recently Secured Funding And More: Glucotrack&#39;s Plans To Transform The Continuous Glucose Monitoring Market

Movers & Shakers

Continuous Blood Glucose Monitoring Can Materially Improve The Quality Of Life For People With Diabetes – Glucotrack Wants To Make It Easier

Comments

GlucoTrack

GlucoTrack (GCTK) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell